Jerome B Zeldis - Net Worth and Insider Trading

Jerome B Zeldis Net Worth

The estimated net worth of Jerome B Zeldis is at least $1 Million dollars as of 2024-12-26. Jerome B Zeldis is the Director of PTC Therapeutics Inc and owns about 14,500 shares of PTC Therapeutics Inc (PTCT) stock worth over $657,575. Jerome B Zeldis is the Director of NexGel Inc and owns about 106,664 shares of NexGel Inc (NXGL) stock worth over $505,587. Jerome B Zeldis is also the Director of BioSig Technologies Inc and owns about 10,794 shares of BioSig Technologies Inc (BSGM) stock worth over $15,975. Besides these, Jerome B Zeldis also holds Soligenix Inc (SNGX) , NexImmune Inc (NEXI) , Sorrento Therapeutics Inc (SRNE) , Adynxx Inc (ADYX) . Details can be seen in Jerome B Zeldis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jerome B Zeldis has not made any transactions after 2024-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jerome B Zeldis

Jerome B Zeldis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jerome B Zeldis owns 9 companies in total, including Soligenix Inc (SNGX) , BioSig Technologies Inc (BSGM) , and PTC Therapeutics Inc (PTCT) among others .

Click here to see the complete history of Jerome B Zeldis’s form 4 insider trades.

Insider Ownership Summary of Jerome B Zeldis

Ticker	Comapny	Transaction Date	Type of Owner
SNGX	Soligenix Inc	2021-09-23	director
BSGM	BioSig Technologies Inc	2020-05-28	director
PTCT	PTC Therapeutics Inc	2024-12-02	director
		2018-11-26	See Remarks
		2017-10-11	director
		2017-06-30	director
		2017-03-14	director
		2024-11-20	director
		2021-02-17	EVP of R&D

Jerome B Zeldis Latest Holdings Summary

Jerome B Zeldis currently owns a total of 7 stocks. Among these stocks, Jerome B Zeldis owns 14,500 shares of PTC Therapeutics Inc (PTCT) as of December 2, 2024, with a value of $657,575 and a weighting of 55.75%. Jerome B Zeldis owns 106,664 shares of NexGel Inc (NXGL) as of November 20, 2024, with a value of $505,587 and a weighting of 42.87%. Jerome B Zeldis also owns 10,794 shares of BioSig Technologies Inc (BSGM) as of May 28, 2020, with a value of $15,975 and a weighting of 1.35%. The other 4 stocks Soligenix Inc (SNGX) , NexImmune Inc (NEXI) , Sorrento Therapeutics Inc (SRNE) , Adynxx Inc (ADYX) have a combined weighting of 0.03% among all his current holdings.

Latest Holdings of Jerome B Zeldis

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PTCT	PTC Therapeutics Inc	2024-12-02	14,500	45.35	657,575
NXGL	NexGel Inc	2024-11-20	106,664	4.74	505,587
BSGM	BioSig Technologies Inc	2020-05-28	10,794	1.48	15,975
SNGX	Soligenix Inc	2021-05-14	95	2.86	272
NEXI	NexImmune Inc	2021-02-17	235	0.20	47
SRNE	Sorrento Therapeutics Inc	2017-02-03	10,000	0.00	7
ADYX	Adynxx Inc	2017-02-27	11,446	0.00	1

Holding Weightings of Jerome B Zeldis

Jerome B Zeldis Form 4 Trading Tracker

According to the SEC Form 4 filings, Jerome B Zeldis has made a total of 2 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 24,000 shares on December 2, 2024, which brought Jerome B Zeldis around $1 Million.

According to the SEC Form 4 filings, Jerome B Zeldis has made a total of 5 transactions in NexGel Inc (NXGL) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in NexGel Inc is the acquisition of 3,636 shares on November 20, 2024, which cost Jerome B Zeldis around $9,999.

According to the SEC Form 4 filings, Jerome B Zeldis has made a total of 1 transactions in BioSig Technologies Inc (BSGM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BioSig Technologies Inc is the acquisition of 100 shares on May 28, 2020, which cost Jerome B Zeldis around $10,490.

More details on Jerome B Zeldis's insider transactions can be found in the Insider Trading History of Jerome B Zeldis table.

Insider Trading History of Jerome B Zeldis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jerome B Zeldis Trading Performance

GuruFocus tracks the stock performance after each of Jerome B Zeldis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jerome B Zeldis is 11.75%. GuruFocus also compares Jerome B Zeldis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jerome B Zeldis within 3 months outperforms 4 times out of 13 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jerome B Zeldis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jerome B Zeldis

Average Return

Average return per transaction

Outperforming Transactions

5 out of 12 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	5.71
Relative Return to S&P 500(%)	6.12

Jerome B Zeldis Ownership Network

Ownership Network List of Jerome B Zeldis

No Data

Ownership Network Relation of Jerome B Zeldis

Jerome B Zeldis Owned Company Details

What does Soligenix Inc do?

Who are the key executives at Soligenix Inc?

Jerome B Zeldis is the director of Soligenix Inc. Other key executives at Soligenix Inc include CMO Richard Straube , director & Chairman & CEO and President Christopher Schaber , and Chief Financial Officer Jonathan L. Guarino .

Soligenix Inc (SNGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Soligenix Inc (SNGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soligenix Inc (SNGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Soligenix Inc (SNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soligenix Inc Insider Transactions

No Available Data

What does BioSig Technologies Inc do?

Who are the key executives at BioSig Technologies Inc?

Jerome B Zeldis is the director of BioSig Technologies Inc. Other key executives at BioSig Technologies Inc include director & 10 percent owner Kenneth L Londoner , Chief Financial Officer Steven J Buhaly , and Chief Operating Officer John Sieckhaus .

BioSig Technologies Inc (BSGM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioSig Technologies Inc (BSGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSig Technologies Inc (BSGM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioSig Technologies Inc (BSGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioSig Technologies Inc Insider Transactions

No Available Data

What does PTC Therapeutics Inc do?

Who are the key executives at PTC Therapeutics Inc?

Jerome B Zeldis is the director of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include Exec. VP and CLO Mark Elliott Boulding , EVP Research Pharma Ops & Tech Neil Gregory Almstead , and Principal Financial Officer Christine Marie Utter .

PTC Therapeutics Inc (PTCT) Insider Trades Summary

Over the past 18 months, Jerome B Zeldis made 2 insider transaction in PTC Therapeutics Inc (PTCT) with a net sale of 44,000. Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,455 shares made by Matthew B. Klein , a net sale of 100,097 shares made by Mark Elliott Boulding , and a net sale of 75,166 shares made by Neil Gregory Almstead .

In summary, during the past 3 months, insiders sold 209,318 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 209,318 shares. During the past 18 months, 295,600 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 287,900 shares.

PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

PTC Therapeutics Inc Insider Transactions

No Available Data

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

Jerome B Zeldis is the See Remarks of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and 10 percent owner Abg Management Ltd .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Therapeutics Inc Insider Transactions

No Available Data

What does MetaStat Inc do?

Who are the key executives at MetaStat Inc?

Jerome B Zeldis is the director of MetaStat Inc. Other key executives at MetaStat Inc include VP OF FINANCE AND SECRETARY Daniel H Schneiderman , and 10 percent owner Richard W Perkins .

MetaStat Inc (MTST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MetaStat Inc (MTST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MetaStat Inc (MTST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MetaStat Inc (MTST)'s detailed insider trading history can be found in Insider Trading Tracker table.

MetaStat Inc Insider Transactions

No Available Data

What does Adynxx Inc do?

Who are the key executives at Adynxx Inc?

Jerome B Zeldis is the director of Adynxx Inc. Other key executives at Adynxx Inc include 10 percent owner David Bonderman , CHIEF MEDICAL OFFICER Donald C. Manning , and 10 percent owner Domain Partners Viii, L.p. .

Adynxx Inc (ADYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adynxx Inc (ADYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adynxx Inc (ADYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adynxx Inc (ADYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adynxx Inc Insider Transactions

No Available Data

What does Beyond Air Inc do?

Who are the key executives at Beyond Air Inc?

Jerome B Zeldis is the director of Beyond Air Inc. Other key executives at Beyond Air Inc include director & President & CEO Amir Avniel , Chief Medical Officer Jeff Lynn Myers , and Chief Operating Officer Michael A. Gaul .

Beyond Air Inc (XAIR) Insider Trades Summary

Over the past 18 months, Jerome B Zeldis made no insider transaction in Beyond Air Inc (XAIR). Other recent insider transactions involving Beyond Air Inc (XAIR) include a net purchase of 3,115,290 shares made by Robert Carey , a net purchase of 1,704,401 shares made by Steven A. Lisi , and a net purchase of 39,266 shares made by Erick Lucera .

In summary, during the past 3 months, insiders sold 0 shares of Beyond Air Inc (XAIR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 28,423 shares of Beyond Air Inc (XAIR) were sold and 4,868,957 shares were bought by its insiders, resulting in a net purchase of 4,840,534 shares.

Beyond Air Inc (XAIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Beyond Air Inc Insider Transactions

No Available Data

What does NexGel Inc do?

Who are the key executives at NexGel Inc?

Jerome B Zeldis is the director of NexGel Inc. Other key executives at NexGel Inc include Chief Financial Officer Drapczuk Adam E Iii , CEO and President Adam R. Levy , and 10 percent owner Bezalel Partners Llc .

NexGel Inc (NXGL) Insider Trades Summary

Over the past 18 months, Jerome B Zeldis made 2 insider transaction in NexGel Inc (NXGL) with a net purchase of 13,636. Other recent insider transactions involving NexGel Inc (NXGL) include a net purchase of 45,995 shares made by Scott Robert Henry , a net purchase of 34,823 shares made by Steven Mark Glassman , and a net purchase of 74,894 shares made by Drapczuk Adam E Iii .

In summary, during the past 3 months, insiders sold 3,000 shares of NexGel Inc (NXGL) in total and bought 39,316 shares, with a net purchase of 36,316 shares. During the past 18 months, 3,000 shares of NexGel Inc (NXGL) were sold and 192,120 shares were bought by its insiders, resulting in a net purchase of 189,120 shares.

NexGel Inc (NXGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

NexGel Inc Insider Transactions

No Available Data

What does NexImmune Inc do?

Who are the key executives at NexImmune Inc?

Jerome B Zeldis is the EVP of R&D of NexImmune Inc. Other key executives at NexImmune Inc include VP & Corporate Controller Timothy Stover , Chief Science Officer Mathias Oelke , and Chief Operating Officer Kristi Jones .

NexImmune Inc (NEXI) Insider Trades Summary

Over the past 18 months, Jerome B Zeldis made no insider transaction in NexImmune Inc (NEXI). Other recent insider transactions involving NexImmune Inc (NEXI) include a net sale of 7,825 shares made by Alan S. Roemer ,

In summary, during the past 3 months, insiders sold 0 shares of NexImmune Inc (NEXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,825 shares of NexImmune Inc (NEXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,825 shares.

NexImmune Inc (NEXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

NexImmune Inc Insider Transactions

No Available Data

Jerome B Zeldis Mailing Address

Above is the net worth, insider trading, and ownership report for Jerome B Zeldis. You might contact Jerome B Zeldis via mailing address: 8767 E. Via De Ventura, Suite 190, Scottsdale Az 85258.

Discussions on Jerome B Zeldis

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.